New recessive compound heterozygous variants of RP1L1 in RP1L1 maculopathy
Author:
Corresponding Author:

Xiao-He Yan. Shenzhen Eye Hospital, Jinan University, Shenzhen Eye Institute, Shenzhen 518040, Guangdong Province, China. yanxh1@hotmail.com

Fund Project:

Supported by Shenzhen Science and Technology Program, Shenzhen, China (No.JCYJ20200109145001814; No.SGDX20211123120001001); the National Natural Science Foundation of China (No.81970790); Sanming Project of Medicine in Shenzhen (No.SZSM202011015).

  • Article
  • | |
  • Metrics
  • |
  • Reference [26]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To identify a maculopathy patient caused by new recessive compound heterozygous variants in RP1L1. METHODS: Comprehensive retinal morphological and functional examinations were evaluated for the patient with RP1L1 maculopathy. Targeted sequence capture array technique was used to screen potential pathologic variants. Polymerase chain reaction and Sanger sequencing were used to confirm the screening results. RESULTS: Fundus examination showed round macular lesions appeared in both eyes. Optical coherence tomography showed that the inner segment/outer segment continuity was disorganized and disruptive in the left eye, but it was uneven and slightly elevated in the right eye. Fundus autofluorescence showed patchy hyper-autofluorescence in the macula. Visual field examination indicates central defects in both eyes. Electroretinogram (ERG) and multifocal ERG showed no obvious abnormalities. Fundus fluorescein angiography in the macula showed obviously irregular hyper-fluorescence in the right eye and slightly hyper-fluorescence in the left eye. We found that the proband carried a missense variant (c.1972C>T) and a deletion variant (c.4717_4718del) of RP1L1, which were originated from the parents and formed compound heterozygous variants. Both variants are likely pathogenic according to the ACMG criteria. Multimodal imaging, ERG and detailed medical history are important diagnostic tools for differentiating between acquired and inherited retinal disorders. CONCLUSION: A maculopathy case with detailed retinal phenotype and new recessive compound heterozygous variants of RP1L1 is identified in a Chinese family, which expands the understanding of phenotype and genotype in RP1L1 maculopathy.

    Reference
    1 Albarry MA, Hashmi JA, Alreheli AQ, Albalawi AM, Khan B, Ramzan K, Basit S. Novel homozygous loss-of-function mutations in RP1 and RP1L1 genes in retinitis pigmentosa patients. Ophthalmic Genet 2019;40(6):507-513.
    2 Davidson AE, Sergouniotis PI, MacKay DS, Wright GA, Waseem NH, Michaelides M, Holder GE, Robson AG, Moore AT, Plagnol V, Webster AR. RP1L1 variants are associated with a spectrum of inherited retinal diseases including retinitis pigmentosa and occult macular dystrophy. Hum Mutat 2013;34(3):506-514.
    3 Bowne SJ, Daiger SP, Malone KA, Heckenlively JR, Kennan A, Humphries P, Hughbanks-Wheaton D, Birch DG, Liu Q, Pierce EA, Zuo J, Huang Q, Donovan DD, Sullivan LS. Characterization of RP1L1, a highly polymorphic paralog of the retinitis pigmentosa 1 (RP1) gene. Mol Vis 2003;9:129-137.
    4 Conte I, Lestingi M, den Hollander A, et al. Identification and characterisation of the retinitis pigmentosa 1-like1 gene (RP1L1): a novel candidate for retinal degenerations. Eur J Hum Genet 2003; 11(2):155-162.
    5 Liu Q, Zhou J, Daiger SP, Farber DB, Heckenlively JR, Smith JE, Sullivan LS, Zuo J, Milam AH, Pierce EA. Identification and subcellular localization of the RP1 protein in human and mouse photoreceptors. Invest Ophthalmol Vis Sci 2002;43(1):22-32.
    6 Noel NCL, MacDonald IM. RP1L1 and inherited photoreceptor disease: a review. Surv Ophthalmol 2020;65(6):725-739.
    7 Yamashita T, Liu J, Gao J, LeNoue S, Wang C, Kaminoh J, Bowne SJ, Sullivan LS, Daiger SP, Zhang K, Fitzgerald ME, Kefalov VJ, Zuo J. Essential and synergistic roles of RP1 and RP1L1 in rod photoreceptor axoneme and retinitis pigmentosa. J Neurosci 2009;29(31):9748-9760.
    8 Ruan MZ, Hussnain SA, Thomas A, Mansukhani M, Tsang S, Yannuzzi L. Utility of en-face imaging in diagnosis of occult macular dystrophy with RP1L1 mutation: a case series. Am J Ophthalmol Case Rep 2019;15:100465.
    9 Toland A. Case report: occult macular dystrophy. Optom Vis Sci 2022;99(4):405-412.
    10 Lyons JS. Non-familial occult macular dystrophy. Doc Ophthalmol 2005;111(1):49-56.
    11 Akahori M, Tsunoda K, Miyake Y, Fukuda Y, Ishiura H, Tsuji S, Usui T, Hatase T, Nakamura M, Ohde H, Itabashi T, Okamoto H, Takada Y, Iwata T. Dominant mutations in RP1L1 are responsible for occult macular dystrophy. Am J Hum Genet 2010;87(3):424-429.
    12 Piao CH, Kondo M, Tanikawa A, Terasaki H, Miyake Y. Multifocal electroretinogram in occult macular dystrophy. Invest Ophthalmol Vis Sci 2000;41(2):513-517.
    13 Miyake Y, Tsunoda K. Occult macular dystrophy. Jpn J Ophthalmol 2015;59(2):71-80.
    14 Wang DD, Gao FJ, Li JK, Chen F, Hu FY, Xu GZ, Zhang JG, Sun HX, Zhang SH, Xu P, Tian GH, Wu JH. Clinical and genetic characteristics of Chinese patients with occult macular dystrophy. Invest Ophthalmol Vis Sci 2020;61(3):10.
    15 Tsang SH, Sharma T. Occult macular dystrophy. Adv Exp Med Biol 2018;1085:103-104.
    16 Park SJ, Woo SJ, Park KH, Hwang JM, Chung H. Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2010;51(7):3673.
    17 Fujinami K, Yang L, Joo K, et al. Clinical and genetic characteristics of East Asian patients with occult macular dystrophy (Miyake disease): East Asia Occult Macular Dystrophy Studies Report Number 1. Ophthalmology 2019;126(10):1432-1444.
    18 Kato Y, Hanazono G, Fujinami K, Hatase T, Kawamura Y, Iwata T, Miyake Y, Tsunoda K. Parafoveal photoreceptor abnormalities in asymptomatic patients with RP1L1 mutations in families with occult macular dystrophy. Invest Ophthalmol Vis Sci 2017;58(14):6020-6029.
    19 Manayath GJ, Rokdey M, Verghese S, Ranjan R, Saravanan VR, Narendran V. An extended phenotype of RP1L1 maculopathy - case report. Ophthalmic Genet 2022;43(3):392-399.
    20 Qi YH, Gao FJ, Hu FY, Zhang SH, Chen JY, Huang WJ, Tian GH, Wang M, Gan DK, Wu JH, Xu GZ. Next-generation sequencing-aided rapid molecular diagnosis of occult macular dystrophy in a Chinese family. Front Genet 2017;8:107.
    21 Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, Makiyama Y, Morooka S, Matsuda F, Yoshimura N. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci 2014;55(11):7369-7375.
    22 Luoma-Overstreet G, Jewell A, Brar V, Couser N. Occult macular dystrophy: a case report and major review. Ophthalmic Genet 2022;43(5):703-708.
    23 Hiraoka M, Ishikawa A, Matsuzawa F, Aikawa SI, Sakurai A. A variant in the RP1L1 gene in a family with occult macular dystrophy in a predicted intrinsically disordered region. Ophthalmic Genet 2020;41(6):599-605.
    24 Yang LZ, Joo K, Tsunoda K, et al. Spatial functional characteristics of East Asian patients with occult macular dystrophy (miyake disease); EAOMD report No. 2. Am J Ophthalmol 2021;221:169-180.
    25 Fujinami K, Kameya S, Kikuchi S, et al. Novel RP1L1 variants and genotype-photoreceptor microstructural phenotype associations in cohort of Japanese patients with occult macular dystrophy. Invest Ophthalmol Vis Sci 2016;57(11):4837-4846.
    26 Nakamura N, Tsunoda K, Mizuno Y, et al. Clinical stages of occult macular dystrophy based on optical coherence tomographic findings. Invest Ophthalmol Vis Sci 2019;60(14):4691-4700.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Wen-Chao Cao, Qing-Shan Chen, Run Gan,/et al.New recessive compound heterozygous variants of RP1L1 in RP1L1 maculopathy. Int J Ophthalmol, 2024,17(1):107-112

Copy
Share
Article Metrics
  • Abstract:106
  • PDF: 579
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:June 02,2023
  • Revised:November 28,2023
  • Online: December 21,2023